Schonfeld Strategic Advisors LLC Champions Oncology, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$7.51 - $10.12 $953,019 - $1.28 Million	-126,900 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$7.89 - $12.23 $97,836 - $151,652	-12,400 Reduced 8.9%	126,900 $1.24 Million
Q4 2018 Feb 14, 2019	BUY	$7.29 - $15.27 $104,247 - $218,361	14,300 Added 11.44%	139,300 $1.09 Million
Q3 2018 Nov 14, 2018	BUY	$5.82 - $17.47 $727,500 - $2.18 Million	125,000 New	125,000 $2.18 Million

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.